Research Interests
The design of biomaterials for a range of biomedical applications, with a focus on understanding and controlling adaptive immune responses. Most materials investigated are created from molecular assemblies- proteins, peptides or bioconjugates that self-organize into useful structures such as nanofibers, gels, and particles.
Selected Grants
University Training Program in Biomolecular and Tissue Engineering
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1994 - 2027Supramolecular biomaterials for tuning the inflammatory properties of the complement system
ResearchPrincipal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2022 - 2027Sublingual Supramolecular Vaccines and Immunotherapies
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2026Duke Center for Advancement of Child Health (CAtCH).
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2021 - 2026Engineered immunotherapies neutralizing interleukin-22 binding protein
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2025Pharmacological Sciences Training Grant
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2020 - 2025Basic Immunology Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2020 - 2025Supramolecular pediatric HIV vaccine design
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2019 - 2025Engineering Adaptive Immune Responses from Hydrogel Scaffolds to Promote Tissue Regeneration
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2020 - 2025Effects of storage method on intestinal allograft immune profile and viability
ResearchCo Investigator · Awarded by Department of Defense · 2019 - 2024Supramolecular peptide immunotherapies for peanut allergy
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2024CIVICs A - Option 23C
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2023Creating the next generation peptide vaccine directed at cytomegalovirus antigens in malignant brain
ResearchInvestigator · Awarded by National Pediatric Cancer Foundation, Inc. · 2022 - 2023Immunomodulatory Biomaterials via Peptide and Protein Self-Assembly
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2023Acquisition of a Biacore T200 Surface Plasmon Resonance Instrument for Shared Use
EquipmentMajor User · Awarded by North Carolina Biotechnology Center · 2022 - 2023Novel Adjuvants and Carriers for Opiod Vaccines
ResearchCo Investigator · Awarded by National Institutes of Health · 2014 - 2020Pharmacological Sciences Training Program
Inst. Training Prgm or CMEParticipating Faculty Member · Awarded by National Institutes of Health · 1975 - 2020Supramolecular nanofiber vaccines
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2015 - 20194th Bioengineering & Translational Medicine Conference
ConferencePrincipal Investigator · Awarded by North Carolina Biotechnology Center · 2019 - 2019Supramolecular matrix materials for prostate cancer cell biology
ResearchPrincipal Investigator · Awarded by University of Illinois at Chicago · 2018 - 2019Supramolecular matrix materials for prostate cancer cell biology
ResearchPrincipal Investigator · Awarded by University of Chicago · 2016 - 2018Acquisition of a MALDI-TOF Mass Spectrometer System at Duke University
EquipmentMajor User · Awarded by North Carolina Biotechnology Center · 2017 - 2018Modular Biomaterials for Targeted Anti-Cytokine Immunotherapies
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2016 - 2017External Relationships
- Johns Hopkins University
- University of Chicago
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.